CD44 and breast carcinoma: After stratification of these specimens based on LIPH expression, we found that the percentage of CD44+/CD24− CSCs in LIPH + TNBC specimens was significantly higher than the percentage in the corresponding LIPH‐ breast cancer (Figure 1C).